X-Message-Number: 8145 From: John de Rivaz <> Newsgroups: sci.cryonics Subject: Re: BioTime advances Date: Sun, 27 Apr 1997 10:59:40 +0100 Message-ID: <> References: <> <> As I understand it - others may correct me - Biotime is a company engaged in research aimed at the medical establishment, but it does have cryonicsts as investors and the substantial growth in the share price has benefited the cryonics organisation(s) that are investors. I do not have the exact figures to hand, but I think the stock quotation has risen by a factor of about fifteen times over the last couple of years. This may be due to the fact that the stock is tighly held, and lightly traded ie there are few sellers. There probably was a seller recently when there was a dip in the price, but the announcement I copied to this NG was accompanied by a sharp recovery. Anyone dealing in the stock will probably affect the price as stock jobbers will mark it up (if bought) or down (if sold) when business is offered, before making the deal. This is the price at the end of Friday DAYS (00s) SYMBL SECURITY CLOSE CHANGE VOL ---------------------------------------------------------------------- April 21 BTIM Biotime............................ 28 1/2 -1 3/4 400 22 BTIM Biotime............................ 25 3/4 -2 3/4 1146 23 BTIM Biotime............................ 25 3/8 - 3/8 785 24 BTIM Biotime............................ 27 1/2 +2 1/8 1599 25 BTIM Biotime............................ 31 +3 1/2 5288 Small Bio stocks are not like electronics stocks, they can rise sharply on good news and then fall sharply as financiers realise that regulatory delays will mean five or more years wait until the products appear on pharmacy shelves and profits in the accounts. However they can be bought after the subsequent fall to benefit from the eventual rise in profits, or a possible takover by a major company wanting the patents. The larger companies, such as Warner Lambert, have so many products that the rise is steady and indeed some commentators have said that they are taking on the characteristics of go-go electronics stocks. New technology has vastly increased the throughput of exploratory research by factors of thousands to one. The regulatory delay means that this pharmaceuticals boom will not be seen on balance sheets until a few years into the next decade, but in the meantime it is a good prop against bad news on current activities. In article: <> (Randy) writes: > > > On Sat, 26 Apr 1997 09:54:41 +0100, John de Rivaz > <> wrote: > > > Biotime and Abbott in licensing pact > > > snipped.... > > John, are these guys doing actual cryonics research. or just > cryobiology research? > Randy > Cryonics: Gateway to the Future? > http://members.wbs.net/homepages/c/r/y/cryofan1.html > *********************************** > > -- ***************************************** Sincerely, * Longevity Report * * http://www.longevb.demon.co.uk/lr.htm * John de Rivaz * Fractal Report * * http://www.longevb.demon.co.uk/fr.htm * * Music I like - see homepage * ***************************************** In the information age, sharing can increase world wealth enormously, because giving information does not decrease your information. http://ourworld.compuserve.com/homepages/JohndeR Fast loading, very few slow pictures Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=8145